Saposin c-dops: a novel anti-tumor agent
CA 2522833 C · Owner: Qi, Xiaoyang · Inventors: Qi, Xiaoyang
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods for treating subjects with disorders characterized by hyper-proliferating cells such as tumors and cancers are provided. The compositions comprise agents that are combinations of saposin C ( or prosaposin-related polypeptides and dioleoylphosphatidylserine ( or inner leaflet components ). This anti-tumor agent is administered in the methods of the invention according to a dosing regimen. Administering an agent of the invention results in a positive therapeutic response in a subject with a tumor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 17, 2004 and granted January 19, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 17, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.